To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Venrock raises nearly $450m for oversubscribed biotech fund
New York venture firm Venrock has raised nearly $450 million for an evergreen vehicle that will invest in both private and public biotech companies.
